Healthcare Industry News: HSMN NewsFeed
News Release - August 24, 2017
Exclusive Agreement to Co-market Proprietary Software Platform to Aid in Total Hip Replacement Announced Between DePuy Synthes and JointPoint, Inc.Hip Navigation System allows for Digital Templating and Precise Analysis of Implant Selection and Positioning During Surgery
WARSAW, Ind., Aug. 24, 2017 -- (Healthcare Sales & Marketing Network) -- Today, DePuy Synthes* announces an exclusive U.S. agreement with JointPoint, Inc. to co-market its proprietary software platform to provide an easy-to-use, surgeon-friendly navigation system that can help deliver improvements in surgical outcomes. JointPoint's software provides non-invasive computer navigation, pre-surgical digital templating, case planning, and feedback while performing total hip replacement surgeries. JointPoint easily integrates with the Anterior Approach. The Anterior Approach is a minimally invasive surgical approach that allows a surgeon to work around the muscles, rather than cut through them, to get to the hip joint.
Adding the JointPoint software to a surgeon's protocol may help reduce leg length discrepancy and complications related to inaccurate cup placement and final implant selection – two of the most important considerations in hip replacement surgery – by providing pre-surgical digital templating and real-time, data-driven surgical decision making in the operating room.
"We are thrilled to partner with JointPoint to help provide more predictive outcomes for surgeons and their patients," said Aaron Villaruz, Global Hip Platform Leader, DePuy Synthes Joint Reconstruction. "By providing access to important information at key stages of the hip replacement process, together we can help surgeons streamline cases and allow for pre-surgical goals to be achieved more consistently."
One of the important features of the JointPoint software is OneTrial™, which can predict optimal implant combinations based on pre-surgical goals using just two images during surgery. Unique to DePuy Synthes implants is the ability of OneTrial™ to also provide precise recommendations on implant size and position to enable more confident adjustments and reduce OR time and fluoroscopy by eliminating re-trialing. Additionally, the JointPoint software helps streamline communications through a JointPoint calendar, case sharing, and case planning/collaboration.
"During hip replacement surgery, physicians strive for optimal implant choices and positioning to improve patient satisfaction by achieving proper leg length, offset, and cup positioning. JointPoint Hip Navigation System gives surgeons the confidence with real time feedback so they can ultimately help restore patients back to their natural function efficiently while minimizing fluoroscopy," said Dr. Andrew J. Cooper**, MD. "I'm excited about what JointPoint can offer those surgeons whose patients are good candidates for the Anterior Approach."
DePuy Synthes will begin co-marketing the JointPoint software in the second half of 2017.
About DePuy Synthes Companies
DePuy Synthes Companies, part of the Johnson & Johnson Medical Devices Companies***, provides one of the most comprehensive orthopaedics portfolios in the world. DePuy Synthes Companies solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. For more information, visit www.depuysynthes.com.
About JointPoint, Inc.
JointPoint, Inc. develops and markets software-driven medical technology for orthopaedics. The JointPoint software solution and OneTrial™ technology is a completely non-invasive navigation system for hip replacement surgery that provides intraoperative data and guides component selection while also optimizing efficiency within a surgical workflow. For more information, visit http://www.jointpoint.com
*DePuy Synthes represents the products and services of DePuy Synthes, Inc. and its affiliates.
**Consultant to DePuy Synthes Joint Reconstruction with an ownership interest in JointPoint, Inc.
***The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopaedics, and cardiovascular businesses within Johnson & Johnson's Medical Devices segment.
©DePuy Synthes 2017. All rights reserved.
The third-party trademarks used herein are the trademarks of their respective owners.
Source: DePuy Synthes
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsTRUMATCH(R) Titanium 3D-Printed Implants Launch in the U.S.
DePuy Synthes Launches Single Use Kits For Wrist Fracture Surgery To Enhance Operating Room Efficiency And Eliminate Procedural Sterilization Costs
DePuy Synthes Announces Acquisition of Sentio, LLC to Enable Innovation in Minimally Invasive Spine Surgery